AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05489120 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Consumption of FLAVIS
Description: Patients of the FLAVIS group will recevied FLAVIS products in addition to their diet follow-up.
Study NCT05552976 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mezigdomide
Description: Specified dose on specified days
Study NCT05552976 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carfilzomib
Description: Specified dose on specified days
Study NCT05552976 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Specified dose on specified days
Study NCT05552976 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Specified dose on specified days
Study NCT05552976 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Specified dose on specified days
Study NCT05019495 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PrOMOTE
Description: This is an opt-out, proactive approach to tobacco treatment by a clinical pharmacy specialist. The pharmacist will call patients and offer an individualized pharmacotherapy prescription. The patient must opt-out for it not to be sent to their pharmacy. The patient will also receive brief motivational interviewing and behavioral counseling from the pharmacist.
Study NCT06660836 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Mouthguard
Description: After the participants' records are taken with intraoral scanners, custom mouthguards will be prepared from soft EVA sheets in a dental laboratory setting.
Study NCT06660836 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Performance test
Description: Participants will undergo the Yo-Yo performance test both while using and not using mouthguards prepared with a digital workflow.
Study NCT06657989 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reactive balance training
Description: Reactive balance training involves clients experiencing repeated balance perturbations so that they can practice and improve control of reactions to avoid falling after a loss of balance.
Study NCT06657989 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Reactive balance training
Description: Reactive balance training involves clients experiencing repeated balance perturbations so that they can practice and improve control of reactions to avoid falling after a loss of balance.
Study NCT06437613 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Passive Static Stretching exercises for 30 seconds
Description: Intervention includes Following Tests~1. Passive Hip Flexion Test(PHFT)~2. Straight Leg Raises(SLR)~3. Modified Knee Extension Test(MKET)
Study NCT06437613 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Passive Static Stretching exercises for 60 seconds
Description: Intervention includes Following Tests~1. Passive Hip Flexion Test(PHFT)~2. Straight Leg Raises(SLR)~3. Modified Knee Extension Test(MKET)
Study NCT03489434 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Preliminary prevention program component content is based on evidence-based prevention programs and will integrate prevention content for substance use, sexual assault, and sexual risk behaviors.
Study NCT06151639 — intervention group
Intervention type: PROCEDURE
Intervention: general anesthesia
Description: General anesthesia was performed by muscle relaxant(rocuronium 0,6 mg/kg), opioids(phentanyl 1-2 mcg/kg) and propofol 2mg/kg. Inhation anesthetics and remiphentanyl infusion were used for maintance general anesthesia.
Study NCT06151639 — intervention group
Intervention type: PROCEDURE
Intervention: peripheral nerve blocks
Description: With the help of ultrasonography, at the 2nd rib level, between the fasciae of the pectoralis major and minor muscles at the mid-clavicle level (PECS I block, interpectoral fascial plane block) and at the 4th rib level, at the mid-axillary level, between the fasciae of the pectoralis minor and serratus muscles (PECS II block, pectoroseratal fascial plane block) local anesthesia was applied. In patients who underwent PECS block, a high-frequency linear ultrasonography (Esaote, My LabFive-Genova, Italy) probe and a 50 mm tip insulated needle (echoplex+, Vygon Ecouen-France) were used. 0.200% bupivacaine 15 ml was applied for the PECS I block, and 0.200% bupivacaine 20 ml was applied for the PECS II block, and fascial separation was observed. Sensory control was performed in the breast and axilla area and the patients were taken into surgery.
Study NCT06657989 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Walking
Description: Overground walking
Study NCT04848220 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temanogrel
Description: Participants will receive a single intravenous dose of temanogrel on Day 1 (Day 1 of PCI procedure)
Study NCT04848220 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive a single intravenous dose of temanogrel matching placebo on Day 1
Study NCT06129071 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: US guided block of maxillary nerve
Description: Extraoral ultrasound-guided block of the maxillary nerve will be performed in the examined group using an ultrasound device and local anesthetic levobupivacaine (0,5%, 2 mL) combined with triamcinolonacetonid (2mL).
Study NCT05576883 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Transdiagnostic emotion regulation intervention
Description: The intervention under study includes 5 therapeutic approaches, namely: Positive psychology \[PP\], Mindfulness, Acceptance and Commitment Therapy \[ACT\], Breathing and relaxation, and Self-compassion \[SC\].~The intervention consists of 4 core features:~(i) monitoring through filling in EMAs assessing participants emotional states~(ii) feedback through visualization of participant emotional states upon every completion of the EMAs~(iii) exercises targeting different emotion regulation skills \[i.e., upregulation of positive affect, mindfulness, cognitive defusion, breathing and relaxation, self-compassion) and health facts (i.e., control intervention) describing health information including nutrition, exercise, sleeping habits.~(iv) psychoeducative articles describing the 5 therapeutic approaches (PP, ACT, Mindfulness, Breathing and Relaxation, SC)
Study NCT05340829 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ThisCART19A
Description: ThisCART19A is a new type CAR-T cells therapy for patients with lymphoma and lympholeukemia
Study NCT04867174 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Financial incentives
Description: Each of the study arms, including the no message/control arm, will be interacted with different financial incentives (N=5,000)
Study NCT04867174 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Financial incentives
Description: Each of the study arms, including the no message/control arm, will be interacted with different financial incentives (N=5,000)
Study NCT04867174 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Convenient scheduling link
Description: In addition, study arms will be randomly assigned a convenient link to the county public vaccine appointment scheduling system highlighted for participants (N=5,000).
Study NCT04867174 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Convenient scheduling link
Description: In addition, study arms will be randomly assigned a convenient link to the county public vaccine appointment scheduling system highlighted for participants (N=5,000).
Study NCT04867174 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Race concordant
Description: Randomized to a messenger who is race concordant with the participant
Study NCT04867174 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gender concordant
Description: Randomized to a messenger who is gender concordant with the participant
Study NCT05204082 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Single Use Vein Entry Indicator Device
Description: Electronic pressure sensing device, integrated to a conventional needle catheter, and which indicates continuously during intravenous cannulation whether the tip of the needle is inside or outside of a vein, to assist a clinician in intravenous cannulation.
Study NCT05540704 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: iACT
Description: Treatment is based on Acceptance and Commitment Therapy (ACT), a contemporary cognitive behavioral therapy (CBT) that improves human functioning and adaptability by increasing psychological flexibility. Individual therapy sessions are paired with mobile phone delivered interventions.
Study NCT05540704 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Usual care for problems in Type 1 diabetes management
Study NCT05583305 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Imaging assessment
Description: Investigators shall perform cranial MRI examinations. The scanning protocol will employ an MRI scan protocol with T1-weighted, T2-weighted, FLAIR, susceptibility weighted imaging, diffusion weighted imaging, and time-of-flight magnetic resonance angiography (MRA) sequences. In addition, high-resolution magnetic resonance vessel wall imaging (HRMRI) allows assessment of the vessel wall using specific the SPACE sequence and the MATCH sequence. Assessors of the HRMRI images shall be blinded to the group allocation and clinical information.
Study NCT05583305 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Neurosonology assessment
Description: Investigators shall perform carotid duplex ultrasonography (CD) assessment, focusing on the peak systolic (PSV) and end diastolic velocity (EDV) of bilateral extracranial internal carotid arteries (ICA) Brightness mode imaging shall gauge the intimal thickness and plaque characteristics (if any) of bilateral ICAs.
Study NCT05583305 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood Test
Description: Nine milliliters of EDTA blood will be drawn during the research clinic visit for evaluation of the degree of neurovascular inflammation. Serum plasminogen activator inhibitor-1 (PAI-1) and high-sensitive C-reactive protein (hsCRP) are markers of vascular inflammation, atherosclerosis, and thrombotic risk. Serum neurofilament light chain (NfL) is a biomarker for neuroaxonal injury that correlates with small vessel disease.
Study NCT05853744 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lavender essential oil inhaled using cotton balls
Description: cotton balls impregnated with 3 drops of lavender essential oil inhaled from a distance of 10 cm during 20 minutes and pure oxygen administered through a face mask.
Study NCT06347068 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: iC9-CAR.B7-H3 T Cell Therapy
Description: iC9-CAR.B7-H3 T cells will then be administered intravenously
Study NCT05853744 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: lavender essential oil inhaled using face mask
Description: These three drops were already diluted by five milliliters of distilled water and were sprayed in the area by a nebulizer throughout a face mask. A cotton ball soaked with water was put 10 cm next to the patient.
Study NCT05853744 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Distilled water
Description: inhaled five milliliters of distilled water in the same way as the patients in the experimental group and also cotton balls with 3 drops of water are placed near the patient.
Study NCT03609320 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The STOP-HPV Trial 5: Bundle Intervention
Description: This intervention will implement a 3-component bundle intervention (communication skills training, performance feedback and prompts) together in practices that previously received standard of care.
Study NCT06552013 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MERV 13 filter
Description: This is an environmental intervention consisting of a low-cost box fan with a MERV 13 filter placed behind it. The company Lasko makes these fans and other environmental appliances.
Study NCT06552013 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sham filter
Description: This is an environmental intervention consisting of a low-cost box fan with a sham filter (MERV 1) placed behind it. The company Lasko makes these fans and other environmental appliances.
Study NCT05501990 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health intervention based on intelligent applet
Description: Patients are jointly managed by a MDT team based on the applet. The supportive intervention based on the applet mainly includes three parts: Nutrition, psychology, and patient management which includes four main parts: Cancer patient education, self-management, patient community, and real-time communication.
Study NCT05260580 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: No Intervention: Routine care
Study NCT05248802 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo caplet of DLBS2411
Description: 1 caplet of placebo DLBS2411, twice daily
Study NCT05248802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DLBS2411
Description: 1 caplet of DLBS2411 250 mg, twice daily
Study NCT06216665 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Continuous Insulin administration during hyperinsulinemic euglycemic clamp test
Description: Participants will receive insulin delivered continuously during the hyperinsulinemic euglycemic clamp test
Study NCT06216665 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pulsatile Insulin administration during hyperinsulinemic euglycemic clamp test
Description: Participants will receive insulin delivered every five minutes during the hyperinsulinemic euglycemic clamp test
Study NCT05010122 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine and Cedazuridine
Description: Given PO
Study NCT05010122 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gilteritinib
Description: Given PO
Study NCT05010122 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given PO
Study NCT04580914 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Treatment with IntellaNav StablePoint Ablation Catheter
Description: Patients will be treated with an ablation catheter
Study NCT04985409 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Feedback
Description: The system uses Sonifi health (TV content and visualizations) and Fitabase (3rd party server to process Fitbit data and export to Sonifi). The system utilizes the patient's TVs to engage the patient and multidisciplinary team in monitoring ambulation status.
Study NCT05617924 — intervention group
Intervention type: PROCEDURE
Intervention: Physical Therapy
Description: Therapy methods using physical agents in treatment
Study NCT06457776 — intervention group
Intervention type: PROCEDURE
Intervention: Dental management
Description: The oral conditions of the included patients will be evaluated at baseline. When indicated, dental extractions will be performed before the beginning of Antiresorptive Therapy. Patients will then receive a six-months intervals follow-up, during which primary and secondary prevention of dental diseases will be performed.
Study NCT06347068 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: cyclophosphamide 300 mg/m2 IV will be given.
Study NCT06347068 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fludarabine
Description: fludarabine 30 mg/m2 IV will be given.
Study NCT06664333 — intervention group
Intervention type: OTHER
Intervention: Semi-structured interviews
Description: The study consists of conducting two semi-structured interviews, with an estimated duration of 15 to 30 minutes, with siblings of children hospitalized in pediatric intensive care at Necker-Enfants Malades Hospital and Robert Debré Hospital.~The first interview will take place during the stay in intensive care, the second 1 month after discharge from pediatric intensive care.
Study NCT06666257 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Continuous Glucose and E-Monitoring to Support Healthy Weight Gain in Pregnancy
Description: The intervention we are basing our adaptations on is a ecological momentary intervention, meaning it is integrated into participants daily lifestyle and schedule. Using an established framework for tracking daily body weight and physical activity, a gestational weight gain trajectory is estimated. Based on the data, recommendation prompts for exercise and diet will be send automatically to participants. For the CGM piece, participants will wear unblinded CGM devices and have access to CGM linked app features that allow insights and reactivity to personal glycemic data
Study NCT06666257 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: E-Monitoring to Support Healthy Weight Gain in Pregnancy
Description: The intervention we are basing our adaptations on is a ecological momentary intervention, meaning it is integrated into participants daily lifestyle and schedule. Using an established framework for tracking daily body weight and physical activity, a gestational weight gain trajectory is estimated. Based on the data, recommendation prompts for exercise and diet will be send automatically to participants
Study NCT05701748 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stimuli
Description: placement of oral pacifier, electrical stimulation, and laryngoscopy
Study NCT06665737 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Early receiving G-CSF group
Description: Early receiving G-CSF group will be given within 72 hours post chemotherapy
Study NCT06665737 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Late receiving G-CSF group
Description: Late receiving G-CSF group will be given after 72 hours post chemotherapy
Study NCT06436872 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: informing patients with using a booklet
Description: The intervention group was informed before discharge and was given an information booklet. A phone number was given so that the researcher could contact the nurse. In the 4th week, 8th week and 12th week, information was given according to the information needs of the patient and caregiver.
Study NCT06372002 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Stimulation Therapy (CST)
Description: The intervention will consist of the Spanish adapted version of Cognitive Stimulation Therapy (CST) followed by the Maintenance CST program.~CST is a cognitive intervention for treating mild to moderate dementia consisting of fourteen 45-minute group sessions that take place twice a week for 7 weeks. Each session follows a main topic (reminiscing about the person's life, current events, word games...) and is led by two group facilitators. The same structure is followed in every CST session: 1. Introduction (5 minutes). 2. Main Activity (25 minutes). 3. Closing (5 minutes).~The Maintenance CST program follows the principles and structure of the original CST program and consists of 24 sessions, one per week, that will be administered after the original program.~The topic, activities, and materials required for each session are specified in the CST-ES manuals, which also provide the key principles that should guide the intervention and other information necessary for its implementation.
Study NCT05381116 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Avation System
Description: Subjects will perform therapy with active Avation System three (3) times a week for thirty (30) minutes each time over a 12-week period. At the end of the twelve (12) weeks of therapy, eligible Subjects from the Active Arm will be offered the opportunity to participate in the additional twenty one (21) month Open-Label Phase.
Study NCT05381116 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Avation System
Description: Subjects will perform therapy with sham Avation System three (3) times a week for thirty (30) minutes each time over a 12-week period. At the end of the twelve (12) weeks of therapy, all Subjects from the Sham Arm will be offered the opportunity to crossover and participate in the additional twenty one (21) month Open-Label Phase.
Study NCT06016088 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RSP-1502
Description: RSP-1502 is a sterile, preservative free solution to be administered by inhalation via a nebulizer. Each dose of RSP-1502 contains the active components tobramycin (300 mg) and CaEDTA in a 5 mL solution.
Study NCT06016088 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tobramycin inhalation solution
Description: Tobramycin inhalation solution is 300 mg tobramycin in 5 mL solution.
Study NCT04988724 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise training
Description: Exercise training with aerobic and strength training, 30 min per session
Study NCT06609005 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INV-9956
Description: INV-9956 is co-administered with dexamethasone and fludrocortisone acetate
Study NCT04803604 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CASCADE (CAre Supporters Coached to be Adept DEcision partners)
Description: CASCADE (CAre Supporters Coached to be Adept DEcision partners) is a multicomponent, lay coach-led supportive care intervention designed to increase family caregivers' skills in providing decision support to individuals with advanced cancer. In a series of weekly, one-on-one, 15-20 minute, in-person or telephone sessions, family caregivers receive psychoeducation on principles of providing effective social support and decision partnering, decision support communication, and Ottawa Decision Guide training as well as monthly follow-up.